Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) affects over 850 million people worldwide and is projected to become a leading cause of death by 2040. Kidney care is resource-intensive, contributing to greenhouse gas (GHG) emissions, water and energy consumption, and healthcare costs. Addressing sustainability in CKD management is critical for aligning kidney health delivery systems with global climate and health goals. A multidisciplinary narrative review was undertaken to qualitatively synthesize literature on CKD management, integrating clinical nephrology, environmental sustainability, and planetary-health perspectives. Studies examining dialysis, kidney transplantation (KT), and preventive kidney management (PKM) were analyzed through the Triple Bottom Line (TBL) framework, encompassing environmental, economic, and social dimensions. Dialysis, though life-sustaining for people with CKD G4-G5, is the least sustainable option due to its high ecological footprint and cost. KT often provides superior survival and long-term cost-effectiveness but faces barriers such as donor availability, inequitable access, and procedural and pharmaceutical emissions. PKM, including early detection, lifestyle improvements, appropriate virtual care, and optimized pharmacologic management, is important for slowing disease progression and may reduce the need for resource-intensive kidney replacement therapy (KRT). Although the environmental and economic effects of PKM have not been consistently quantified, avoiding or delaying progression to advanced CKD may reduce healthcare resource use, costs, and environmental impacts. Findings support a coordinated, value-based model of kidney care that aligns preventive, interventional, and supportive practices, while recognizing gaps in environmental and economic evidence. Embedding sustainability into CKD care will necessitate technological innovation, policy reform, and equitable access. Future collaborative research should employ long-term life-cycle assessments to guide sustainable, patient-centered kidney care. It should account for variability in CKD pathways and balance effectiveness, sustainability, and equitable access worldwide.
No takes yet. Share an insight, caveat, or question.
Yousafzai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: